Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

PledPharma publ announces futility analysis in PLIANT study completed and approved by the DSMB


Monday, 18 Aug 2014 02:30am EDT 

PledPharma publ AB:Says futility analysis in PLIANT study completed and approved by the DSMB.Says analysis covers first 30 patients in study who have completed 4 treatment cycles with chemotherapy mixture FOLFOX. 

Company Quote

23.0
0.5 +2.22%
15 Sep 2014